Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Submitted by
admin
on September 3, 2013 - 11:07am
Source:
Forbes
News Tags:
diabetes
saxagliptin
alogliptin
AstraZeneca
Bristol-Myers Squibb
Takeda
Headline:
Is 'No Worse Than Placebo' Good Enough For New Diabetes Drugs?
Do Not Allow Advertisers to Use My Personal information
